Managing Glycemic Variability: What GLP1 Agonists & DPP 4 Inhibitors Mean | Dr. Bryan Walsh [keto ripped gummies reviews]

Managing Glycemic Variability: What GLP1 Agonists & DPP 4 Inhibitors Mean | Dr. Bryan Walsh [keto ripped gummies reviews]

| 1h 28m 28s | Video has closed captioning.

Are you looking for a better way to manage your patients' glycemic variability? If so, you're in the right place. In this video, we'll discuss how functional medicine can help, and what emerging therapeutic agents like GLP1 agonists and DPP 4 inhibitors can do to help you better manage glycemic variability. So if you're looking for the latest in functional medicine advice on glycemic variability, this is a must-watch. Tune in now! VIDEO RESOURCE: ======================== This video is from Clinician's Code, a full-scale learning experience for health professionals looking to better help their patients and build a thriving, evidence-based functional medicine practice. You can learn more here - FREE RESOURCE: ======================== If you enjoyed this video, check out the free One Day Functional Medicine Course here – ABOUT DR. BRYAN WALSH ======================== Dr. Walsh has been studying human physiology and nutrition for over 25 years and has been educating others in health for 20 of those years. When he isn’t teaching, he spends his time pouring over the latest research and synthesizing his findings into practical information for clinicians to use in practice. Dr. Walsh is best known for his expertise in biochemistry and human physiology, which allows him to (happily) dismantle the myths and misconceptions in the functional medicine industry and replace them with the truth. His work is most often described as, “the functional medicine education you always wanted, but never received".